WallStreetZenWallStreetZen

NASDAQ: KYMR
Kymera Therapeutics Inc Stock Ownership - Who owns Kymera Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Kymera Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Pamela EspositoDirector2026-01-202,500$49.10
$122.75kBuy
Pamela EspositoDirector2026-01-203,000$31.20
$93.60kBuy
Pamela EspositoDirector2026-01-20400$66.68
$26.67kSell
Pamela EspositoDirector2026-01-204,900$67.99
$333.15kSell
Pamela EspositoDirector2026-01-20200$68.52
$13.70kSell
Nello MainolfiChief Executive Officer2026-01-053,118$32.07
$99.99kBuy
Nello MainolfiChief Executive Officer2025-12-3130,000$2.08
$62.40kBuy
Nello MainolfiChief Executive Officer2025-12-316,014$78.52
$472.21kSell
Nello MainolfiChief Executive Officer2025-12-3123,986$77.95
$1.87MSell
Pamela EspositoDirector2025-12-1712,563$49.10
$616.84kBuy

1 of 9

KYMR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KYMR insiders and whales buy or sell their stock.

KYMR Shareholders

What type of owners hold Kymera Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP11.06%7,955,916$601.63MInsider
Baker Bros Advisors LP9.24%6,651,429$502.98MInstitution
Avoro Capital Advisors LLC8.83%6,350,000$480.19MInstitution
Fmr LLC8.17%5,879,611$444.62MInstitution
Atlas Venture Associates X LP8.01%5,763,012$435.80MInsider
Atlas Venture Fund X LP7.65%5,504,905$416.28MInsider
Bvf Inc7.65%5,502,710$416.11MInstitution
Vanguard Group Inc7.54%5,421,722$409.99MInstitution
Wellington Management Group LLP7.22%5,195,691$392.90MInstitution
Price T Rowe Associates Inc7.08%5,097,378$385.46MInstitution

1 of 3

KYMR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KYMR75.15%24.85%Net BuyingNet Buying
MIRM52.20%47.80%Net BuyingNet Buying
PTGX82.83%17.17%Net SellingNet Selling
COGT91.97%8.03%Net SellingNet Selling
BLTE7.19%0.00%
View Top Biotech Stocks

Kymera Therapeutics Stock Ownership FAQ

Who owns Kymera Therapeutics?

Kymera Therapeutics (NASDAQ: KYMR) is owned by 112.40% institutional shareholders, 37.16% Kymera Therapeutics insiders, and 0.00% retail investors. Baker Bros Advisors LP is the largest individual Kymera Therapeutics shareholder, owning 7.96M shares representing 11.06% of the company. Baker Bros Advisors LP's Kymera Therapeutics shares are currently valued at $614.36M.

If you're new to stock investing, here's how to buy Kymera Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.